| GTO ID | GTC0716 |
| Trial ID | ACTRN12622000675729 |
| Disease | Diffuse Midline Glioma |
| Altered gene | GD2 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | GD2 CAR-T cells |
| Recruitment status | Recruiting |
| Title | Leveraging Chimeric Antigen Receptor-Expressing T Cells for Children with Diffuse Midline Glioma |
| Year | 2022 |
| Country | Australia |
| Company sponsor | Sydney Children's Hospitals Network |
| Cohort 1 | |||||||||||||
|
|||||||||||||